ROOT stock news
This page provides real-time market news, earnings updates, and company announcements related to Root, Inc. (ROOT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 02:50 EST
Shopify, eBay receive upgrades: Leading analyst recommendations from Wall Street
101 finance2026-02-19 14:48:41
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
Finviz2026-02-19 16:33:05
Etsy Q4 2025 Earnings Call Transcript
Finviz2026-02-19 16:48:40
Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference
Finviz2026-02-22 21:03:42
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
Finviz2026-02-23 13:34:20
Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week
Finviz2026-02-23 15:36:02
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
BioMarin Pharmaceutical's (NASDAQ:BMRN) Q4 CY2025 Sales Beat Estimates
Finviz2026-02-23 21:54:08
Root (ROOT) Reports Q4: Everything You Need To Know Ahead Of Earnings
Finviz2026-02-24 03:15:40
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Finviz2026-02-24 17:33:10
2 Nasdaq 100 Stocks You Should Watch and 1 That Raises Concerns
101 finance2026-02-25 12:21:55
Dyne Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-25 12:33:45
Oddity Stock Craters As Company Forecasts Severe Revenue Decline
Finviz2026-02-25 16:13:23
Root, Inc. Announces 2025 Fourth Quarter and Full Year Results
Finviz2026-02-25 21:18:46
Root (NASDAQ:ROOT) Delivers Strong Q4 CY2025 Numbers, Stock Jumps 12.2%
Finviz2026-02-25 21:39:43
Johnson & Johnson's 0.45% Mysterious Slide Without Clear Catalyst Despite 54th-Ranked $1.87B Volume
101 finance2026-02-25 22:33:36
Regeneron Gains 1.57% as FDA Decision Nears, Trading Volume Ranks 207th
101 finance2026-02-25 23:24:45
TransMedics Group Stock Plunges 4.3% as $350M Surge Propels It to 390th Most Traded Amid Mystery
101 finance2026-02-26 00:22:03
authID Selected by Point of Sale Lender to Provide Fraud Prevention and Identity Assurance
Finviz2026-02-26 13:03:43
Morgan Stanley: Even Bigger Than the Dot-Com Bubble! Tech Giants Bet $2 Trillion on AI, Unprecedented Capital Intensity
美股ipo2026-02-26 13:53:39
Ultragenyx Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application (BLA) for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
Finviz2026-02-23 13:34:20
Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week
Finviz2026-02-23 15:36:02
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Finviz2026-02-23 16:03:11
BioMarin Pharmaceutical's (NASDAQ:BMRN) Q4 CY2025 Sales Beat Estimates
Finviz2026-02-23 21:54:08
Root (ROOT) Reports Q4: Everything You Need To Know Ahead Of Earnings
Finviz2026-02-24 03:15:40
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
Finviz2026-02-24 12:03:56
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
Finviz2026-02-24 12:03:57
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
Finviz2026-02-24 17:33:10
2 Nasdaq 100 Stocks You Should Watch and 1 That Raises Concerns
101 finance2026-02-25 12:21:55
Dyne Therapeutics to Participate in Upcoming Investor Conferences
Finviz2026-02-25 12:33:45
Oddity Stock Craters As Company Forecasts Severe Revenue Decline
Finviz2026-02-25 16:13:23
Root, Inc. Announces 2025 Fourth Quarter and Full Year Results
Finviz2026-02-25 21:18:46
Root (NASDAQ:ROOT) Delivers Strong Q4 CY2025 Numbers, Stock Jumps 12.2%
Finviz2026-02-25 21:39:43
Johnson & Johnson's 0.45% Mysterious Slide Without Clear Catalyst Despite 54th-Ranked $1.87B Volume
101 finance2026-02-25 22:33:36
Regeneron Gains 1.57% as FDA Decision Nears, Trading Volume Ranks 207th
101 finance2026-02-25 23:24:45
TransMedics Group Stock Plunges 4.3% as $350M Surge Propels It to 390th Most Traded Amid Mystery
101 finance2026-02-26 00:22:03
authID Selected by Point of Sale Lender to Provide Fraud Prevention and Identity Assurance
Finviz2026-02-26 13:03:43
Morgan Stanley: Even Bigger Than the Dot-Com Bubble! Tech Giants Bet $2 Trillion on AI, Unprecedented Capital Intensity
美股ipo2026-02-26 13:53:39
ROOT stock chart
ROOT stock detailsROOT stock price change
On the last trading day, ROOT stock closed at 58.23 USD, with a price change of -2.11% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more